Skip to content

Incidence of Erythrocytosis in Patients Receiving Kidney Transplantation and Predictive Factors in Siriraj Hospital

Incidence of Erythrocytosis in Patients Receiving Kidney Transplantation and Predictive Factors in Siriraj Hospital

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20211130002
Enrollment
400
Registered
2021-11-30
Start date
2021-08-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients aged 18 years and older who received kidney transplant at Siriraj Hospital. The patients aged 18 years and older who received kidney transplant at Siriraj Hospital. The patients who were diagnosed with thrombocytopenia after kidney transplantation.

Interventions

The patients aged 18 years and older who received kidney transplant at Siriraj Hospital. The patients who were diagnosed with thrombocytopenia after kidney transplantation between January 1, 2010 and
Other
The patients aged 18 years and older who received kidney transplant at Siriraj Hospital. The patients who were diagnosed with thrombocytopenia after kidney transplantation.

Sponsors

Siriraj Hospital Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The patients aged 18 years and older who received kidney transplant at Siriraj Hospital between January 1, 2010 and December 31, 2020. 2.The patients who were diagnosed with thrombocytopenia after kidney transplantation. - Male: hemoglobin level greater than 16.5 g/dl or hematocrit greater than 49% - Female: hemoglobin level greater than 16 g/dl or hematocrit level The value was greater than 48 percent, 3.The patients received continued follow-up at a kidney transplant clinic for at least 1 year.

Exclusion criteria

Exclusion criteria: 1.The Patients diagnosed with thrombocytopenia prior to kidney transplantation - Male: hemoglobin level greater than 16.5 g/dl or hematocrit level greater than 49% - Female: hemoglobin level greater than 16 g/dl or hematocrit level More than 48 percent 2.The Patients with Leukocytosis 3.The Patients who have received organ transplants other than kidneys. 4.The Patients receiving medication erythropoietin stimulating agents or testosterone drugs. 5.The Patients with a history of lung or heart disease. 6.The Patients with a history of obstructive sleep apnea at the time of thrombosis.

Design outcomes

Primary

MeasureTime frame
The incidence of hematuria hematuria after kidney transplantation. First visit and hematuria after kidney transplantation. Hematuria after kidney transplantation per normal.

Secondary

MeasureTime frame
The causes and predictive factors of blood thickening after kidney transplantation. First clinic visit Basic patient information and laboratory results from medical record and case record form.

Countries

Thailand

Contacts

Public ContactWeerapat Owattanapanich

Division of Hematology,Faculty of Medicine Siriraj Hospital,Mahidol University.

weerapato36733@gmail.com0891081963

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026